Tag Abrocitinib

Upadacitinib is a selective JAK1 inhibitor used for moderate to severe eczema, helping reduce itch, inflammation, and skin symptoms.

Health

JAK Inhibitors for Eczema: Upadacitinib (Rinvoq) and Cibinqo Explained

Rinvoq and Cibinqo comparison for eczema treatment, highlighting oral JAK inhibitors used for fast itch relief and skin clearance in atopic dermatitis.

Not responding to Dupixent? Discover how Rinvoq (upadacitinib) and Cibinqo (abrocitinib) compare for eczema, including effectiveness, safety, fast itch relief, and who may benefit most from these advanced oral JAK inhibitor treatments.

Aisha Saleem
June 24, 2026

JAK Inhibitors for Eczema: Upadacitinib (Rinvoq) and Cibinqo Explained

Trending now